カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

経カテーテル構造心臓デバイスの世界市場2022：左心耳閉塞器、中隔欠損閉塞器、大動脈弁置換術、僧帽弁修復術、僧帽弁置換術（実験的）

◆英語タイトル：Global Transcatheter Structural Heart Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22NO18658）◆商品コード：GIR22NO18658
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年11月（※2025年版があります。お問い合わせください。）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

経カテーテル構造心臓デバイス市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経カテーテル構造心臓デバイスの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経カテーテル構造心臓デバイス市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・左心耳閉塞器、中隔欠損閉塞器、大動脈弁置換術、僧帽弁修復術、僧帽弁置換術（実験的）

用途別セグメントは次のように区分されます。
・先天性心疾患、大動脈弁狭窄症、僧帽弁閉鎖不全症、脳卒中、その他

世界の経カテーテル構造心臓デバイス市場の主要な市場プレーヤーは以下のとおりです。
・Medtronic、Boston Scientific Corporation、Abbott、Edwards Lifesciences Corporation、Lifetech、Braile Biomedica、Micro Interventional Devices、LivaNova PLC、Cryolife、Neovasc、4C Medical Technologies、Highlife、Lepu Medical、Dinova Medtech、NewMed Medical、Venus Medtech、Hanyu Medical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経カテーテル構造心臓デバイス製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経カテーテル構造心臓デバイスメーカーの企業概要、2019年～2022年までの経カテーテル構造心臓デバイスの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経カテーテル構造心臓デバイスメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経カテーテル構造心臓デバイスの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経カテーテル構造心臓デバイスの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経カテーテル構造心臓デバイス市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経カテーテル構造心臓デバイスの産業チェーンを掲載しています。
・第13、14、15章では、経カテーテル構造心臓デバイスの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 経カテーテル構造心臓デバイスの概要
- 種類別分析（2017年vs2021年vs2028年）：左心耳閉塞器、中隔欠損閉塞器、大動脈弁置換術、僧帽弁修復術、僧帽弁置換術（実験的）
- 用途別分析（2017年vs2021年vs2028年）：先天性心疾患、大動脈弁狭窄症、僧帽弁閉鎖不全症、脳卒中、その他
- 世界の経カテーテル構造心臓デバイス市場規模・予測
- 世界の経カテーテル構造心臓デバイス生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Medtronic、Boston Scientific Corporation、Abbott、Edwards Lifesciences Corporation、Lifetech、Braile Biomedica、Micro Interventional Devices、LivaNova PLC、Cryolife、Neovasc、4C Medical Technologies、Highlife、Lepu Medical、Dinova Medtech、NewMed Medical、Venus Medtech、Hanyu Medical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：左心耳閉塞器、中隔欠損閉塞器、大動脈弁置換術、僧帽弁修復術、僧帽弁置換術（実験的）
・用途別分析2017年-2028年：先天性心疾患、大動脈弁狭窄症、僧帽弁閉鎖不全症、脳卒中、その他
・経カテーテル構造心臓デバイスの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経カテーテル構造心臓デバイスのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経カテーテル構造心臓デバイスのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経カテーテル構造心臓デバイスの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・経カテーテル構造心臓デバイスの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Transcatheter Structural Heart Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transcatheter Structural Heart Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Congenital Heart Defects accounting for % of the Transcatheter Structural Heart Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Left Atrial Appendage Occluders segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Transcatheter Structural Heart Device include Medtronic, Boston Scientific Corporation, Abbott, Edwards Lifesciences Corporation, and Lifetech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transcatheter Structural Heart Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Left Atrial Appendage Occluders
Septal Defect Occluders
Aortic Valve Replacement
Mitral Valve Repair
Mitral Valve Replacement (Experimental)
Market segment by Application can be divided into
Congenital Heart Defects
Aortic Stenosis
Mitral Regurgitation
Stroke
Others
The key market players for global Transcatheter Structural Heart Device market are listed below:
Medtronic
Boston Scientific Corporation
Abbott
Edwards Lifesciences Corporation
Lifetech
Braile Biomedica
Micro Interventional Devices
LivaNova PLC
Cryolife
Neovasc
4C Medical Technologies
Highlife
Lepu Medical
Dinova Medtech
NewMed Medical
Venus Medtech
Hanyu Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transcatheter Structural Heart Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transcatheter Structural Heart Device, with price, sales, revenue and global market share of Transcatheter Structural Heart Device from 2019 to 2022.
Chapter 3, the Transcatheter Structural Heart Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transcatheter Structural Heart Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Transcatheter Structural Heart Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transcatheter Structural Heart Device.
Chapter 13, 14, and 15, to describe Transcatheter Structural Heart Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Transcatheter Structural Heart Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transcatheter Structural Heart Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Left Atrial Appendage Occluders
1.2.3 Septal Defect Occluders
1.2.4 Aortic Valve Replacement
1.2.5 Mitral Valve Repair
1.2.6 Mitral Valve Replacement (Experimental)
1.3 Market Analysis by Application
1.3.1 Overview: Global Transcatheter Structural Heart Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Congenital Heart Defects
1.3.3 Aortic Stenosis
1.3.4 Mitral Regurgitation
1.3.5 Stroke
1.3.6 Others
1.4 Global Transcatheter Structural Heart Device Market Size & Forecast
1.4.1 Global Transcatheter Structural Heart Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Transcatheter Structural Heart Device Sales in Volume (2017-2028)
1.4.3 Global Transcatheter Structural Heart Device Price (2017-2028)
1.5 Global Transcatheter Structural Heart Device Production Capacity Analysis
1.5.1 Global Transcatheter Structural Heart Device Total Production Capacity (2017-2028)
1.5.2 Global Transcatheter Structural Heart Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transcatheter Structural Heart Device Market Drivers
1.6.2 Transcatheter Structural Heart Device Market Restraints
1.6.3 Transcatheter Structural Heart Device Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Transcatheter Structural Heart Device Product and Services
2.1.4 Medtronic Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Transcatheter Structural Heart Device Product and Services
2.2.4 Boston Scientific Corporation Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Transcatheter Structural Heart Device Product and Services
2.3.4 Abbott Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Edwards Lifesciences Corporation
2.4.1 Edwards Lifesciences Corporation Details
2.4.2 Edwards Lifesciences Corporation Major Business
2.4.3 Edwards Lifesciences Corporation Transcatheter Structural Heart Device Product and Services
2.4.4 Edwards Lifesciences Corporation Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lifetech
2.5.1 Lifetech Details
2.5.2 Lifetech Major Business
2.5.3 Lifetech Transcatheter Structural Heart Device Product and Services
2.5.4 Lifetech Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Braile Biomedica
2.6.1 Braile Biomedica Details
2.6.2 Braile Biomedica Major Business
2.6.3 Braile Biomedica Transcatheter Structural Heart Device Product and Services
2.6.4 Braile Biomedica Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Micro Interventional Devices
2.7.1 Micro Interventional Devices Details
2.7.2 Micro Interventional Devices Major Business
2.7.3 Micro Interventional Devices Transcatheter Structural Heart Device Product and Services
2.7.4 Micro Interventional Devices Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 LivaNova PLC
2.8.1 LivaNova PLC Details
2.8.2 LivaNova PLC Major Business
2.8.3 LivaNova PLC Transcatheter Structural Heart Device Product and Services
2.8.4 LivaNova PLC Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cryolife
2.9.1 Cryolife Details
2.9.2 Cryolife Major Business
2.9.3 Cryolife Transcatheter Structural Heart Device Product and Services
2.9.4 Cryolife Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Neovasc
2.10.1 Neovasc Details
2.10.2 Neovasc Major Business
2.10.3 Neovasc Transcatheter Structural Heart Device Product and Services
2.10.4 Neovasc Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 4C Medical Technologies
2.11.1 4C Medical Technologies Details
2.11.2 4C Medical Technologies Major Business
2.11.3 4C Medical Technologies Transcatheter Structural Heart Device Product and Services
2.11.4 4C Medical Technologies Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Highlife
2.12.1 Highlife Details
2.12.2 Highlife Major Business
2.12.3 Highlife Transcatheter Structural Heart Device Product and Services
2.12.4 Highlife Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Lepu Medical
2.13.1 Lepu Medical Details
2.13.2 Lepu Medical Major Business
2.13.3 Lepu Medical Transcatheter Structural Heart Device Product and Services
2.13.4 Lepu Medical Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Dinova Medtech
2.14.1 Dinova Medtech Details
2.14.2 Dinova Medtech Major Business
2.14.3 Dinova Medtech Transcatheter Structural Heart Device Product and Services
2.14.4 Dinova Medtech Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 NewMed Medical
2.15.1 NewMed Medical Details
2.15.2 NewMed Medical Major Business
2.15.3 NewMed Medical Transcatheter Structural Heart Device Product and Services
2.15.4 NewMed Medical Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Venus Medtech
2.16.1 Venus Medtech Details
2.16.2 Venus Medtech Major Business
2.16.3 Venus Medtech Transcatheter Structural Heart Device Product and Services
2.16.4 Venus Medtech Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Hanyu Medical
2.17.1 Hanyu Medical Details
2.17.2 Hanyu Medical Major Business
2.17.3 Hanyu Medical Transcatheter Structural Heart Device Product and Services
2.17.4 Hanyu Medical Transcatheter Structural Heart Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Transcatheter Structural Heart Device Breakdown Data by Manufacturer
3.1 Global Transcatheter Structural Heart Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Transcatheter Structural Heart Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Transcatheter Structural Heart Device
3.4 Market Concentration Rate
3.4.1 Top 3 Transcatheter Structural Heart Device Manufacturer Market Share in 2021
3.4.2 Top 6 Transcatheter Structural Heart Device Manufacturer Market Share in 2021
3.5 Global Transcatheter Structural Heart Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Transcatheter Structural Heart Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transcatheter Structural Heart Device Market Size by Region
4.1.1 Global Transcatheter Structural Heart Device Sales in Volume by Region (2017-2028)
4.1.2 Global Transcatheter Structural Heart Device Revenue by Region (2017-2028)
4.2 North America Transcatheter Structural Heart Device Revenue (2017-2028)
4.3 Europe Transcatheter Structural Heart Device Revenue (2017-2028)
4.4 Asia-Pacific Transcatheter Structural Heart Device Revenue (2017-2028)
4.5 South America Transcatheter Structural Heart Device Revenue (2017-2028)
4.6 Middle East and Africa Transcatheter Structural Heart Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Transcatheter Structural Heart Device Sales in Volume by Type (2017-2028)
5.2 Global Transcatheter Structural Heart Device Revenue by Type (2017-2028)
5.3 Global Transcatheter Structural Heart Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Transcatheter Structural Heart Device Sales in Volume by Application (2017-2028)
6.2 Global Transcatheter Structural Heart Device Revenue by Application (2017-2028)
6.3 Global Transcatheter Structural Heart Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Transcatheter Structural Heart Device Sales by Type (2017-2028)
7.2 North America Transcatheter Structural Heart Device Sales by Application (2017-2028)
7.3 North America Transcatheter Structural Heart Device Market Size by Country
7.3.1 North America Transcatheter Structural Heart Device Sales in Volume by Country (2017-2028)
7.3.2 North America Transcatheter Structural Heart Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Transcatheter Structural Heart Device Sales by Type (2017-2028)
8.2 Europe Transcatheter Structural Heart Device Sales by Application (2017-2028)
8.3 Europe Transcatheter Structural Heart Device Market Size by Country
8.3.1 Europe Transcatheter Structural Heart Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Transcatheter Structural Heart Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Transcatheter Structural Heart Device Sales by Type (2017-2028)
9.2 Asia-Pacific Transcatheter Structural Heart Device Sales by Application (2017-2028)
9.3 Asia-Pacific Transcatheter Structural Heart Device Market Size by Region
9.3.1 Asia-Pacific Transcatheter Structural Heart Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Transcatheter Structural Heart Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Transcatheter Structural Heart Device Sales by Type (2017-2028)
10.2 South America Transcatheter Structural Heart Device Sales by Application (2017-2028)
10.3 South America Transcatheter Structural Heart Device Market Size by Country
10.3.1 South America Transcatheter Structural Heart Device Sales in Volume by Country (2017-2028)
10.3.2 South America Transcatheter Structural Heart Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transcatheter Structural Heart Device Sales by Type (2017-2028)
11.2 Middle East & Africa Transcatheter Structural Heart Device Sales by Application (2017-2028)
11.3 Middle East & Africa Transcatheter Structural Heart Device Market Size by Country
11.3.1 Middle East & Africa Transcatheter Structural Heart Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Transcatheter Structural Heart Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Transcatheter Structural Heart Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Transcatheter Structural Heart Device
12.3 Transcatheter Structural Heart Device Production Process
12.4 Transcatheter Structural Heart Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Transcatheter Structural Heart Device Typical Distributors
13.3 Transcatheter Structural Heart Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 経カテーテル構造心臓デバイスの世界市場2022：左心耳閉塞器、中隔欠損閉塞器、大動脈弁置換術、僧帽弁修復術、僧帽弁置換術（実験的）(Global Transcatheter Structural Heart Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 経カテーテル心臓弁置換装置のグローバル市場展望 2023年-2029年：経カテーテル大動脈弁置換装置、経カテーテル僧帽弁置換装置、経カテーテル肺動脈弁置換装置、その他
  • 経カテーテル弁送達デバイスパイプラインの世界市場2022：経カテーテル弁デリバリーデバイスチューブ、経カテーテル静脈弁デリバリーデバイスチューブ
  • 心臓弁耐久性試験機の世界市場2022：ハンドヘルド、ベンチトップ
  • 心臓ポンプ装置の世界市場2022：心室補助装置 (VAD)、大動脈内バルーン ポンプ (IABP)、人工心臓 (TAH)
  • 心臓欠損閉鎖装置の世界市場2022：心房中隔欠損 ( ASD ) 閉鎖デバイス、左心耳 ( LAA ) 閉鎖デバイス、卵円孔開存 ( PFO ) 閉鎖デバイス、動脈管開存 ( PDA ) 閉鎖デバイス、心室中隔欠損 ( VSD ) 閉鎖デバイス、その他